使用创新的智能可穿戴技术预防,评估和管理糖尿病脚:系统审查
Doua Kosaji1, Mohammad I Awad2, Rateb Katmah1
1Biomedical Engineering and Biotechnology Department, Khalifa University, PO. Box 127788, Abu Dhabi, UAE.
Journal of neuroengineering and rehabilitation
|July 18, 2025
概括
糖尿病足是一个主要的健康问题. 新的可穿戴技术和人工智能可以帮助监测和管理这种情况,以改善愈合.
科学领域:
- 生物医学工程 生物医学工程
- 糖尿病管理 糖尿病管理
- 可穿戴技术可穿戴技术
背景情况:
- 糖尿病足 (DF) 并发症在2型糖尿病患者中导致显著的发病率,死亡率和截肢.
- 尽管了解病路径 (神经病变,缺血,感染),但现有的管理策略面临挑战.
- 风力发电给健康和经济带来了巨大的负担.
研究的目的:
- 探索先进的传感方式和智能可穿戴设备的集成,以实现实时的DF管理.
- 弥合在利用技术有效的DF伤口愈合的知识差距.
- 审查目前用于DF评估和治疗的技术解决方案.
主要方法:
- 审查传感,微型可穿戴技术和人工智能的最新技术发展.
- 探索量化机械 (脚部压力,剪切力) 和生理/伤口相关参数 (温度,湿度,血管,微循环,pH) 的探索.
- 传感方式与用于实时监控的新型执行技术的整合.
主要成果:
- 技术进步为DF管理提供了可行的解决方案.
- 持续监测系统可以提醒患者和医疗保健提供者,提高检测和管理.
- 关键参数的量化提供了改善DF评估和治疗结果的机会.
结论:
- 将最先进的传感器和智能可穿戴设备与执行技术相结合,对于实时的 DF 管理至关重要.
- 技术解决方案有望改善DF评估,监测和伤口愈合.
- 可穿戴系统可以提高糖尿病足并发症的早期检测和主动管理.
更多相关视频
相关概念视频
Peripheral Artery Disease IV: Nursing Management
46
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
46
Diabetes: Management and Pharmacotherapy
399
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
399
Diabetes: Symptoms, Diagnosis, and Complications
697
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
697
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
36
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
36
Peripheral Artery Disease V: Postoperative Nursing Management
26
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
26
Peripheral Artery Disease III: Interprofessional Care
30
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
30


